OptimizeRx (OPRX) Share-based Compensation (2010 - 2026)

OptimizeRx has disclosed Share-based Compensation across 16 years of filings, most recently posting $2.2 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 48.39% year-over-year to $2.2 million; the TTM figure through Jun 2026 stood at $8.0 million (up 2.79% YoY), while the FY2025 annual figure was $7.0 million, down 39.29% from the prior year.
• Share-based Compensation came in at $2.2 million for Q2 2026 at OptimizeRx, up from $1.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.3 million in Q3 2022 to a low of $1.5 million in Q2 2025.
• Average Share-based Compensation over 5 years is $2.6 million, with a median of $2.4 million recorded in 2023.
• Year-over-year, Share-based Compensation soared 445.23% in 2022 and plunged 62.41% in 2023.
• Over 5 years, Share-based Compensation stood at $4.3 million in 2022, then slumped by 38.47% to $2.6 million in 2023, then gained by 11.8% to $2.9 million in 2024, then plunged by 33.27% to $2.0 million in 2025, then advanced by 12.65% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $2.2 million in Q2 2026, $1.8 million in Q1 2026, and $2.0 million in Q4 2025.